Accession Number:



Treatment Related Cardiac Toxicity in Patients Treated for Breast Cancer

Descriptive Note:

Final rept. 1 Jun 2002-31 May 2006

Corporate Author:


Personal Author(s):

Report Date:


Pagination or Media Count:



Purpose To determine the incidence dosetime-dependence and functional significance of regional cardiac perfusion abnormalities in patients with left-sided breast cancer treated with radiation therapy RT with and without doxorubicin. Methods 160 patients underwent pre-RT single photon emission computed tomography SPECT cardiac perfusion imaging. Post-RT images were obtained in 125, 95, 56, 43, 24, 28, 21 and 2 patients at 6, 12, 18, 24 36, 48, 60 and 72 months post-RT. SPECT perfusion images were registered onto 3-dimensional 3D RT dose distributions. The volume of heart in the RT field was quantified and the regional RT dose was calculated. Changes in regional and global cardiac function were assessed. Results The incidence of new perfusion defects 6 12 16 24 36 46 and 60 months post RT was 38 35 38 42 52 71 and 67 respectively. In the 44 patients who have longer follow-up beyond 2 years 3044 680 exhibit perfusion defects. New defects occurred in approximately 0-80 and 30-80 of patients with 5 and 5 of their left ventricle included within the RT fields respectively. Perfusion defects were associated with changes in regional wall motion 8-26 of the time and possibly with the development of chest-pain. Patients with extensive perfusion defects may have subtle reductions in ejection fractions. Conclusions RT causes volume-dependent perfusion defects in approximately 42 of patients within two years of RT. These perfusion defects largely persist beyond 2 years and are associated with corresponding wall motion abnormalities and possibly reductions in ejection fraction.

Subject Categories:

  • Medicine and Medical Research
  • Radiobiology

Distribution Statement: